R1 RCM Inc. (RCM): Price and Financial Metrics


R1 RCM Inc. (RCM)

Today's Latest Price: $24.12 USD

1.70 (-6.58%)

Updated Jan 27 4:00pm

Add RCM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 56 in Outsourcing - Business Services

See all "A" rated Strong Buy stocks

RCM Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for RCM is 20.1 -- better than 98.65% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 26.66 for R1 Rcm Inc; that's greater than it is for 98.65% of US stocks.
  • Over the past twelve months, RCM has reported earnings growth of 189.12%, putting it ahead of 92.52% of US stocks in our set.
  • Stocks that are quantitatively similar to RCM, based on their financial statements, market capitalization, and price volatility, are GHL, TLND, KODK, NETE, and LTRPA.
  • RCM's SEC filings can be seen here. And to visit R1 Rcm Inc's official web site, go to www.r1rcm.com.

RCM Stock Price Chart Interactive Chart >

Price chart for RCM

RCM Price/Volume Stats

Current price $24.12 52-week high $27.22
Prev. close $25.82 52-week low $7.12
Day low $24.06 Volume 991,900
Day high $25.41 Avg. volume 940,135
50-day MA $22.84 Dividend yield N/A
200-day MA $16.04 Market Cap 2.81B

R1 RCM Inc. (RCM) Company Bio


R1 RCM Inc. provides revenue cycle management and physician advisory services for healthcare providers in the United States. It offers revenue cycle management services to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides physician advisory services, which offer concurrent level of care billing classification reviews, as well as retrospective chart audits to assist hospitals in properly billing payers for selected services. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is based in Chicago, Illinois.

RCM Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$24.12$128.58 433%

Below please find a table outlining a discounted cash flow forecast for RCM, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that R1 Rcm Inc ranked in the 80th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 435.83% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for RCM, they are:

  • Its compound free cash flow growth rate, as measured over the past 2.49 years, is 0.98% -- higher than 90.41% of stocks in our DCF forecasting set.
  • R1 Rcm Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 21.09% of tickers in our DCF set.
  • As a business, R1 Rcm Inc experienced a tax rate of about 19% over the past twelve months; relative to its sector (Technology), this tax rate is higher than 77.3% of stocks generating free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%423%
1%428%
2%433%
3%438%
4%444%
5%449%

DGII, QRTEA, BNFT, TTMI, and HGBL can be thought of as valuation peers to RCM, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.


RCM Latest News Stream


Event/Time News Detail
Loading, please wait...

RCM Latest Social Stream


Loading social stream, please wait...

View Full RCM Social Stream

Latest RCM News From Around the Web

Below are the latest news stories about R1 Rcm Inc that investors may wish to consider to help them evaluate RCM as an investment opportunity.

What Is R1 RCM Inc.'s (NASDAQ:RCM) Share Price Doing?

R1 RCM Inc. ( NASDAQ:RCM ), is not the largest company out there, but it saw a significant share price rise of over 20...

Yahoo | January 22, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of R1 RCM Inc. - RCM

New York, New York--(Newsfile Corp. - January 18, 2021) - Levi & Korsinsky announces it has commenced an investigation of R1 RCM Inc. (NASDAQ: RCM) concerning possible breaches of fiduciary duty. To obtain additional information, go to:https://www.zlk.com/compensation2/r1-rcm-inc-information-request-formor contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500. There is no cost or obligation to you.Levi & Korsinsky is a nationally recognized firm with offices in New York, ...

Yahoo | January 18, 2021

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating R1 RCM Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of R1 RCM Inc. (NASDAQ: RCM).

Yahoo | January 18, 2021

RBC Capital Stick to Their Buy Rating for R1 RCM Inc By Investing.com

RBC Capital Stick to Their Buy Rating for R1 RCM Inc

Investing.com | January 14, 2021

R1 RCM Announces Conversion Agreement with Ascension and TowerBrook

Conversion of Preferred Stock to Shares of Common Stock to Enhance Alignment with Common ShareholdersAscension and TowerBrook Committed to Supporting Sustainable Long-Term GrowthCHICAGO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, announced that it has entered into an agreement with TCP-ASC ACHI Series LLLP, an investment vehicle jointly owned by Ascension Health Alliance (“Ascension”) and investment funds affiliated with TowerBrook Capital Partners L.P. (“TowerBrook”), for the conversion of all of the 8.00% Series A Convertible Preferred Stock (the “Preferred Stock”) held by the joint investment vehicle to common stock. The Preferred Stock, issued in February 2016, was e...

Yahoo | January 6, 2021

Read More 'RCM' Stories Here

RCM Price Returns

1-mo 1.01%
3-mo 34.60%
6-mo 76.44%
1-year 86.98%
3-year 350.00%
5-year 820.61%
YTD 0.42%
2020 85.05%
2019 63.27%
2018 80.27%
2017 96.00%
2016 -29.69%

Continue Researching RCM

Want to see what other sources are saying about R1 Rcm Inc's financials and stock price? Try the links below:

R1 Rcm Inc (RCM) Stock Price | Nasdaq
R1 Rcm Inc (RCM) Stock Quote, History and News - Yahoo Finance
R1 Rcm Inc (RCM) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8351 seconds.